Ligand Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ligand Pharmaceuticals Inc
TickerLGND
CIK #0000886163
CUSIP53220K504
SectorLife Sciences - Pharmaceutical Preparations
Address11085 North Torrey Pines Road Suite 300, La Jolla, CA 92037
Source [EDGAR]
CIK Filing 2011 - 2025
[0000886163] 10-K
[0000886163] 10-Q
[0000886163] 3
[0000886163] 4
[0000886163] 5
[0000886163] 8-K
[0000886163] D
[0000886163] SC 13D
[0000886163] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Ligand Pharmaceuticals Inc Pelthos Therapeutics Inc [2025-07-03] 0.0
Macquarie Group Ltd Ligand Pharmaceuticals Inc [2024-02-14] 81945.66
Goldman Sachs Group Inc Ligand Pharmaceuticals Inc [2024-02-12] 6.8
State Street Corp Ligand Pharmaceuticals Inc [2021-02-16] 7.25
Macquarie Group Ltd Ligand Pharmaceuticals Inc [2021-02-12] 5.68
Wasatch Advisors Inc Ligand Pharmaceuticals Inc [2021-02-09] 7.3
Cardinal Capital Management LLC /CT Ligand Pharmaceuticals Inc [2020-02-14] 5.2
Bank of America Corp /DE/ Ligand Pharmaceuticals Inc [2020-02-14] 5.8
State Street Corp Ligand Pharmaceuticals Inc [2020-02-14] 7.14
Janus Henderson Group PLC Ligand Pharmaceuticals Inc [2020-01-10] 10.5
Ligand Pharmaceuticals Inc Seelos Therapeutics Inc [2019-04-15] 9.99
Renaissance Technologies LLC Ligand Pharmaceuticals Inc [2019-02-12] 6.97
FMR LLC Ligand Pharmaceuticals Inc [2016-02-12] 0.0
William Blair Investment Management LLC Ligand Pharmaceuticals Inc [2016-02-09] 5.72
KCG Americas LLC Ligand Pharmaceuticals Inc [2016-02-03] 9.63
Ligand Pharmaceuticals Inc Viking Therapeutics Inc [2015-05-08] 49.8
Cardinal Capital Management LLC /CT Ligand Pharmaceuticals Inc [2015-02-12] 5.0
Vanguard Group Inc Ligand Pharmaceuticals Inc [2015-02-10] 5.07
RS Investment Management Co LLC Ligand Pharmaceuticals Inc [2014-02-14] 6.44
FMR LLC Ligand Pharmaceuticals Inc [2014-02-14] 0.0
Blair William & Co/IL Ligand Pharmaceuticals Inc [2014-02-06] 5.96
Vanguard Group Inc Ligand Pharmaceuticals Inc [2013-02-13] 5.32
Ligand Pharmaceuticals Inc Desert Gateway Inc [2013-01-11] 7.44
Park West Asset Management LLC Ligand Pharmaceuticals Inc [2012-12-26] 5.1
BlackRock Inc Ligand Pharmaceuticals Inc [2012-02-09] 6.01
Form 3/4/5 Filer 2011 - 2025
Reardon Andrew
Ligand Pharmaceuticals Inc
Kozarich John W
Pelthos Therapeutics Inc.
Davis Todd C
Espinoza Octavio
Aryeh Jason
Lamattina John L
Zimmermann Martine
Sabba Stephen L
Haas Jason
Gray Nancy Ryan
Korenberg Matthew E
Higgins John L
OmniAb Operations, Inc.
Cochran Jennifer R.
Patel Sunil
Berkman Charles S
Foehr Matthew W
Boyce Sarah
Pfenex Inc.
Viking Therapeutics, Inc.
Goldman Sachs Group Inc
Goldman Sachs & Co LLC
Herman Melanie J
Knott David M
DeSilva Nishan M
Lampert Mark N
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF Investments LLC
BVF Partners L P/IL
BVF Inc/IL
Investment 10 LLC
Sharp John P
Kazmi Syed
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 2,854,789 2,913,596
Vanguard Group Inc [2025-06-30] SOLE 0 2,049,123
Janus Henderson Group PLC [2025-06-30] DFND 0 1,060,734
Macquarie Group Ltd [2025-06-30] SOLE 903,759 926,554
State Street Corp [2025-06-30] DFND 690,225 749,754
Dimensional Fund Advisors LP [2025-06-30] SOLE 644,585 664,688
Congress Asset Management Co [2025-06-30] SOLE 615,717 647,941
Stephens Investment Management Group LLC [2025-06-30] DFND 0 604,813
Chicago Capital LLC [2025-06-30] SOLE 571,825 571,825
Geode Capital Management LLC [2025-06-30] DFND 488,778 488,778
Loomis Sayles & Co L P [2025-06-30] DFND 403,666 410,897
Massachusetts Financial Services Co /MA/ [2025-06-30] SOLE 339,742 339,742
Rice Hall James & Associates LLC [2025-06-30] SOLE 273,334 337,348
Deutsche Bank AG [2025-06-30] DFND 294,027 307,797
Ashford Capital Management Inc [2025-06-30] SOLE 302,527 302,527
Ranger Investment Management LP [2025-06-30] SOLE 261,250 300,025
Villere St Denis J & Co LLC [2025-06-30] SOLE 286,180 287,120
Impax Asset Management Group plc [2025-06-30] DFND 260,208 260,208
Northern Trust Corp [2025-06-30] DFND 255,768 258,667
Invesco Ltd. [2025-06-30] DFND 0 229,858
Private Capital Management LLC [2025-06-30] DFND 72,255 229,253
Aberdeen Group plc [2025-06-30] DFND 229,230 229,230
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 196,950 215,556
Morgan Stanley [2025-06-30] DFND 167,999 202,409
Franklin Resources Inc [2025-06-30] DFND 185,476 186,099
Charles Schwab Investment Management Inc [2025-06-30] SOLE 176,053 176,064
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 131,876 162,810
Driehaus Capital Management LLC [2025-06-30] SOLE 124,589 161,162
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] OTR 1,121 148,350
Bank of New York Mellon Corp [2025-06-30] DFND 116,624 128,106
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com